CRH Medical Corp (TSE:CRH) had its price objective dropped by stock analysts at National Bank Financial from C$7.00 to C$5.25 in a note issued to investors on Friday. The brokerage presently has an “outperform” rating on the stock. National Bank Financial’s price objective indicates a potential upside of 67.20% from the company’s previous close. National Bank Financial also issued estimates for CRH Medical Corp’s Q2 2017 earnings at $0.06 EPS.

CRH has been the subject of a number of other research reports. Scotiabank dropped their target price on shares of CRH Medical Corp from C$10.25 to C$9.75 and set an “outperform” rating for the company in a report on Tuesday, April 25th. Royal Bank Of Canada dropped their target price on shares of CRH Medical Corp from C$8.50 to C$6.00 and set an “outperform” rating for the company in a report on Friday, July 21st. TD Securities dropped their target price on shares of CRH Medical Corp from C$12.00 to C$10.50 and set a “buy” rating for the company in a report on Friday, July 7th. Finally, Bloom Burton lowered shares of CRH Medical Corp from a “buy” rating to an “accumulate” rating in a report on Friday, July 14th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. CRH Medical Corp currently has an average rating of “Buy” and a consensus target price of C$6.75.

CRH Medical Corp (TSE:CRH) traded down 3.38% during trading on Friday, reaching $3.14. 1,923,248 shares of the company traded hands. The company has a market capitalization of $232.11 million and a P/E ratio of 16.70. CRH Medical Corp has a 52 week low of $3.10 and a 52 week high of $12.35. The firm has a 50-day moving average price of $6.16 and a 200-day moving average price of $8.46.

TRADEMARK VIOLATION NOTICE: “National Bank Financial Cuts CRH Medical Corp (TSE:CRH) Price Target to C$5.25” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/08/06/national-bank-financial-cuts-crh-medical-corp-tsecrh-price-target-to-c5-25.html.

In other news, Director David Johnson sold 30,000 shares of the company’s stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of C$5.67, for a total transaction of C$170,100.00.

About CRH Medical Corp

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (TSE:CRH)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.